ichorbio
At ichorbio, their vision is to develop the highest quality reagents to advance scientific research and progress. They believe that the excellence of our products directly impacts the meaningfulness of research outcomes.
What sets ichorbio apart is their commitment to the human impact of their work. They provide reagents that further drug discovery and disease treatment research. But also recognise science is a human endeavor. The team cares deeply about making positive change through our operations and philanthropy.
ichorbio was born out of a vision - that business can move science forward, while still being rooted in humanity. As they progress, their founding spirit continues to drive them.

ichorbio – Trusted Experts in In Vivo Antibodies & Research Biosimilars
ichorbio is your go-to source for high-quality, scalable reagents designed specifically for in vivo research. While best known for their innovation and reliability, many researchers are still discovering that ichorbio offers a standout range of in vivo antibodies, isotype controls, and research biosimilars — ideal for preclinical studies and beyond.
With a firm commitment to scientific progress and human impact, ichorbio’s team understands that your research depends on consistency, reproducibility, and ethical production. Their reagents are not only backed by scientific rigour — they’re delivered with purpose.
Whether you're conducting target validation, efficacy studies, or mechanistic research, ichorbio provides a wide array of products tailored to support every stage of your drug discovery pipeline. Their portfolio includes:
Anti-mouse antibodies for preclinical models
HLA antibodies to support humanised systems
Research-grade biosimilars, including conjugated biosimilars, to mimic therapeutic action
A complete selection of in vivo isotype controls for accurate data interpretation
Explore ichorbio’s in vivo tools today and accelerate your research with confidence.
Why Choose ichorbio for your research?
Specialised focus on in vivo-ready antibodies
Rapid, scalable solutions for preclinical research
Competitive pricing with global availability
Human-first values and sustainable operations

Featured Product Categories
Products by Research Area
anti-human | <1 EU/mg endotoxin | 1mg - 100mg | >95% Purity
Cancer Antibodies
4-1BB | B7-H3 |
B7-H4 ICH5181 | CD27 ICH5022 |
CD28 ICH5023 | CD40 ICH5030, ICH5031, ICH5032, ICH5129 |
CD47 ICH5034, ICH5036 | CD70 ICH5037 |
CD80 | CTLA-4 ICH4025, ICH5184, ICH5185, ICH5192 |
LAG3 ICH5067, ICH5098, ICH5117 | OX40 |
PD-1 ICH4009, ICH4029, ICH5001, ICH5002, ICH5003, ICH5004, ICH5161 | PD-L1 ICH4017, ICH4018, ICH5005 |
TIGIT ICH5078, ICH5159 | Tim-3 ICH5079 |
VISTA ICH5081 | PD-1 x CTLA-4 ICH5113, ICH5208 |
PD-1 x CTLA-4 ICH5113, ICH5208 | CTLA-4 x LAG3 ICH5203 |
Cardiovascular Antibodies
Angiopoietin 2 | ANGPTL3 |
Carbonic Anhydrase IX ICH5013 | CD140a ICH5100 |
CD51 ICH5138 | CD73 ICH5038, ICH5136 |
EGFL7 ICH5175 | F9xF10 ICH5178 |
FGFR2b | GPIIb/IIIa ICH5056 |
IFNB1 ICH5220 | NT5E ICH5131 |
VEGF ICH4003, ICH4015, ICH4031 | VEGFR2 ICH4032 |
VISTA ICH5081 | VWF ICH5082 |
Neuroscience Antibodies
ADM | Amyloid beta |
CALCA, CALCB ICH5044 | CD195 ICH1178 |
CD56 ICH1015 | CGRP ICH5045, ICH5046 |
CGRP Receptor ICH5043 | DLL3 ICH5048 |
Ganglioside GD2 | MAPT ICH5125, ICH5126 |
NGF ICH5012, ICH5152, ICH5157 | RTN4 ICH5173 |